Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Abbreviated, acid, Alberta, amino, Attorney, bladder, Brazil, chemotherapy, closure, employee, Epp, facility, Germany, harm, heavy, hydrochloride, indemnification, leave, noncurrent, packaging, pathway, Paulinia, Paulo, PRELUDE, progression, raloxifene, Regulation, relapse, sale, Sao, sequence, setoff, Trademark, translation, weaker
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 11 Exhibit 11. Statement Re: Computation of Earnings Per Share
- 12 Exhibit 12. Statement Re: Computation of Ratio of Earnings (Loss) to Fixed Charg
- 31.1 Exhibit 31.1 Rule 13A-14(A) Certification of John C. Lechleiter, Chairman, Presi
- 31.2 Exhibit 31.2 Rule 13A-14(A) Certification of Derica W. Rice, Executive Vice Pres
- 32 Exhibit 32. Section 1350 Certification
Related press release
LLY similar filings
Filing view
External links